Sims Investment Management LLC Has $339,000 Stake in UnitedHealth Group Incorporated $UNH

Sims Investment Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,087 shares of the healthcare conglomerate’s stock after acquiring an additional 41 shares during the period. Sims Investment Management LLC’s holdings in UnitedHealth Group were worth $339,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Nabity Jensen Investment Management Inc increased its stake in UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares during the last quarter. Atlantic Edge Private Wealth Management LLC increased its stake in UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 25 shares during the last quarter. Osborne Partners Capital Management LLC increased its stake in UnitedHealth Group by 2.5% in the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock valued at $558,000 after buying an additional 26 shares during the last quarter. HHM Wealth Advisors LLC increased its stake in UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares during the last quarter. Finally, MPS Loria Financial Planners LLC increased its stake in UnitedHealth Group by 0.4% in the 1st quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock valued at $3,800,000 after buying an additional 27 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $356.53 on Friday. The company has a market capitalization of $322.90 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50-day simple moving average of $329.38 and a 200 day simple moving average of $343.62. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on UNH shares. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Robert W. Baird reissued an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. KeyCorp lifted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Finally, Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.